FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 296:1372-1377 June 16, 1977 Number 24 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We observed severe infection with herpes simplex virus in cardiac-transplant patients despite their high serum antibody levels to this virus. Therefore, we sought to correlate clinical susceptibility to two herpesvirus (simplex and zoster) infections with specific cellular immunity, assessed by the transformation and interferon responses of peripheral blood mononuclear cells to heat-inactivated antigens. Transformation and interferon response to herps simplex virus was maximally depressed immediately after transplantation, the time when severe and prolonged infection with herps simplex virus occurred. Six months to six years after transplantation, both clinical susceptibility and cellular immunity to herpes simplex virus were normal. Herpes zoster infections were more frequent than normal at all times after cardiac transplantation; depressed or absent cellular responses to the varicella zoster virus paralleled that susceptibility. In these patients the risk of severe herpesvirus infections correlated with depressed cellular immune responses to the specific viral agent involved.

This article has been cited by other articles:

• Cheng, H., Tumpey, T. M., Staats, H. F., van Rooijen, N., Oakes, J. E., Lausch, R. N. (2000). Role of Macrophages in Restricting Herpes Simplex Virus Type 1 Growth after Ocular Infection. IOVS 41: 1402-1409 [Abstract] [Full Text]  
• WADE, J. C., NEWTON, B., FLOURNOY, N., MEYERS, J. D. (1984). Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation. ANN INTERN MED 100: 823-828 [Abstract]  
• SARAL, R., AMBINDER, R. F., BURNS, W. H., ANGELOPULOS, C. M., GRIFFIN, D. E., BURKE, P. J., LIETMAN, P. S. (1983). Acyclovir Prophylaxis Against Herpes Simplex Virus Infection in Patients with Leukemia: A Randomized, Double-Blind, Placebo-Controlled Study. ANN INTERN MED 99: 773-776 [Abstract]  
• Rand, K. H., Jacobson, D. G., Cottrell, C. R., Koch, K. L., Guild, R. T., McGuigan, J. E. (1983). Antibodies to Herpes Simplex Type 1 in Patients With Active Duodenal Ulcer. Arch Intern Med 143: 1917-1920 [Abstract]  
• WADE, J. C., NEWTON, B., McLAREN, C., FLOURNOY, N., KEENEY, R. E., MEYERS, J. D. (1982). Intravenous Acyclovir to Treat Mucocutaneous Herpes Simplex Virus Infection After Marrow Transplantation: A Double-Blind Trial. ANN INTERN MED 96: 265-269 [Abstract]  
• STIEHM, E. R., KRONENBERG, L. H., ROSENBLATT, H. M., BRYSON, Y., MERIGAN, T. C. (1982). Interferon: Immunobiology and Clinical Significance. ANN INTERN MED 96: 80-93 [Abstract]  
• Vonderheid, E. C., Milstein, H. J., Thompson, K. D., Wu, B. C. (1980). Chronic Herpes Simplex Infection in Cutaneous T-Cell Lymphomas. Arch Dermatol 116: 1018-1022 [Abstract]  
• GALLAGHER, J. G., MERIGAN, T. C. (1979). Prolonged Herpes-Zoster Infection Associated with Immunosuppressive Therapy. ANN INTERN MED 91: 842-846 [Abstract]  
• Blank, H. (1979). Herpetism. Arch Dermatol 115: 1440-1441 [Abstract]  
• Mazur, M. H., Whitley, R. J., Dolin, R. (1979). Serum Antibody Levels as Risk Factors in the Dissemination of Herpes Zoster. Arch Intern Med 139: 1341-1345 [Abstract]  
• KING, G. W., GROZEA, P. C., EYRE, H. J., LoBUGLIO, A. F. (1979). Neoantigen Response in Patients Successfully Treated for Lymphoma: A Southwest Oncology Group Study. ANN INTERN MED 90: 892-895 [Abstract]  
• DOLIN, R., REICHMAN, R. C., MAZUR, M. H., WHITLEY, R. J. (1978). Herpes Zoster-Varicella Infections in Immunosuppressed Patients. ANN INTERN MED 89: 375-388 [Abstract]